Charles River Laboratories International (NYSE:CRL – Get Free Report) and Mesa Laboratories (NASDAQ:MLAB – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends and risk.
Institutional and Insider Ownership
98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 2.8% of Mesa Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility & Risk
Charles River Laboratories International has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Mesa Laboratories has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500.
Profitability
This table compares Charles River Laboratories International and Mesa Laboratories’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Charles River Laboratories International | 1.01% | 16.95% | 6.93% |
| Mesa Laboratories | 2.65% | 22.77% | 10.19% |
Valuation & Earnings
This table compares Charles River Laboratories International and Mesa Laboratories”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Charles River Laboratories International | $4.02 billion | 4.00 | -$144.34 million | $0.91 | 368.45 |
| Mesa Laboratories | $251.32 million | 3.00 | $6.71 million | $1.14 | 117.62 |
Mesa Laboratories has lower revenue, but higher earnings than Charles River Laboratories International. Mesa Laboratories is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent recommendations for Charles River Laboratories International and Mesa Laboratories, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Charles River Laboratories International | 1 | 3 | 12 | 0 | 2.69 |
| Mesa Laboratories | 0 | 3 | 1 | 0 | 2.25 |
Charles River Laboratories International currently has a consensus price target of $311.67, suggesting a potential downside of 7.05%. Mesa Laboratories has a consensus price target of $130.00, suggesting a potential downside of 3.05%. Given Mesa Laboratories’ higher probable upside, analysts clearly believe Mesa Laboratories is more favorable than Charles River Laboratories International.
About Charles River Laboratories International
Charles River Laboratories International is a contract research organization that supports pharmaceutical and biotechnology companies, as well as academic and government researchers, in developing medicines and advancing scientific research. Its services span the drug development process, from early discovery and preclinical research to manufacturing support. The company’s offerings include research models and related services, drug discovery and safety assessment, and manufacturing solutions. These may include laboratory animal models, laboratory testing, bioanalysis, and support for the production of products used in the development of pharmaceuticals and biologics.
About Mesa Laboratories
Mesa Laboratories, Inc. develops and manufactures instruments and consumable products used to monitor and control quality in life sciences and other regulated industries. Its offerings support activities such as sterilization and disinfection monitoring, laboratory testing, biopharmaceutical development, and equipment calibration. The company’s products include biological and chemical indicators, data loggers, calibration instruments, and tools used in clinical genomics and bioprocessing. Customers use these products to help verify processes, measure conditions, and meet quality requirements.
Receive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.
